Anyone flipping out over a little day like today is a muppet. Today was a nice day because we were given insight into the fact that things are ticking along.
Look at the lifecycle of the company: is it where it should be? Yes. Look at the multi-year chart: is it intact? Yes.
This is a mid- to long-term proposition and if the company strategy stays on track the SP will eventually go UP. All investors need to be is patient, and vigilant in case the mid- to long-term thesis breaks down.
The next serious leg up in the chart can happen quickly, even over a couple of weeks. Those weeks could be within the next 2 months, or those weeks could be in a years time after the SP undulates sideways or even downwards. No-one knows.
It shouldn't even matter, unless you're one of those HC fantasists who thinks they should be doubling their bank every year on **promotion blocked**. And if you think that's even remotely possible, you are a classic stockmarket mug.
- Forums
- ASX - By Stock
- PAR
- Building a sizeable position - Portfolio allocation
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.20%
!
46.5¢

Building a sizeable position - Portfolio allocation, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
46.5¢ |
Change
0.010(2.20%) |
Mkt cap ! $182.8M |
Open | High | Low | Value | Volume |
45.5¢ | 48.0¢ | 44.0¢ | $334.7K | 725.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 57022 | 45.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.5¢ | 19163 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 57022 | 0.455 |
6 | 37510 | 0.450 |
3 | 25247 | 0.445 |
5 | 92548 | 0.440 |
1 | 84714 | 0.435 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 19163 | 2 |
0.470 | 2000 | 1 |
0.475 | 1718 | 3 |
0.480 | 111975 | 5 |
0.485 | 23497 | 4 |
Last trade - 11.55am 04/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online